HealthPhoto: NDTV BusinessIndia Expands Price Controls on 137 Anti-Cancer Drugs
India has added 137 non-scheduled anti-cancer drugs to its price control list, aiming to reduce prices by up to 70%. The Ministry of Chemicals and Fertilizers announced the move to make treatments more affordable in the $2.6 billion oncology market. The price caps, effective from November 9, include immunotherapy drugs for 20 cancer types, potentially saving patients 25 billion rupees annually.
NDTV Business·



